Cancer Clinical Trials
This is a current listing of active clinical trials at the Aspirus Regional Cancer Center. From this list you can select a specific cancer that you are interested in (for example, breast or colon cancer) and then review the clinical trials that are active at the Aspirus Regional Cancer Center for that specific disease.
Esophageal Cancer Treated without Surgery
Trial Name: A Phase III Trial Evaluating The Addition of Cetuximab To Paclitaxel, Cisplatin, and Radiation For Patients With Esophageal Cancer Who Are Treated Without Surgery.
Protocol ID: RTOG 0436
Women who are nursing.
Enrollment: About 420 people will take part in this study.
Taking part in this study may or may not make your health better. While researchers hope radiation therapy, chemotherapy, and cetuximab will be more useful against cancer compared to the usual treatment, there is no proof of this yet. We do know that the information from this study will help researchers learn more about this therapy combination as a treatment for a cancer. This information could help future cancer patients.
These clinical trial overviews are intended to provide a brief overview of the clinical trial. To help determine whether the trial is appropriate for you, the major eligibility criteria are listed above. To obtain more information on the eligibility and the treatment plan, please contact our Oncology Clinical Research Coordinator, Beth Knetter at 715-847-2353 or 1-800-283-2881, ext.72353.
Created: Aug 18, 2009
Updated: Jan 18, 2013